AG

Abhay Gupta

Active Director Director DIN 09576050
DIN 09576050 First appointment Apr 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Abhay Gupta

Data last updated:

Abhay Gupta is a Director at Muditam Ayurveda Private Limited (since 2022). The company operates in Healthcare. Muditam Ayurveda Private Limited reported revenue of ₹7.12 Cr (FY 2025).

DIN 09576050
Primary Designation Director
Industry Healthcare
First Appointment 19 Apr 2022
Oldest Company Age 4 yrs
Largest company Muditam Ayurveda Private Limited · ₹7.12 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Muditam Ayurveda Private Limited U51909HP2022PTC009277
Director19 Apr 20222022₹7.12 Cr (FY 2025)Active

Board colleagues of Abhay Gupta

Directorship timeline

Open interactive timeline →
Muditam Ayurveda Private Limited
Premium access

Shareholding and investment profile for Abhay Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhay Gupta

Abhay Gupta currently holds 1 directorship: Muditam Ayurveda Private Limited (Director, since 19 Apr 2022, revenue ₹7.12 Cr (FY 2025)).

Abhay Gupta was first appointed on 19 Apr 2022 as Director at Muditam Ayurveda Private Limited.

The current boards of Abhay Gupta's companies include Asit Kant Gupta (Muditam Ayurveda Private Limited), Madhur Sachdev (Muditam Ayurveda Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available